Avalyn Pharma Inc. Common Stock
Avalyn Pharma Inc. Common Stock (AVLN) Stock Competitors & Peer Comparison
See (AVLN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVLN | $27.27 | -0.58% | 1.1B | -13.37 | -$2.04 | N/A |
| ONC | $313.32 | +5.32% | 33.5B | 126.85 | $2.47 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +2.09% |
| DMRA | $24.69 | -0.72% | 1.5B | -6.19 | -$3.98 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| CGEM | $14.99 | +0.33% | 921.2M | -4.46 | -$3.36 | N/A |
| ATAI | $4.17 | +4.25% | 787.5M | -1.43 | -$2.91 | N/A |
| LFMD | $5.27 | +2.73% | 253.1M | -17.58 | -$0.30 | N/A |
| HITI | $2.49 | +5.06% | 218.4M | -5.92 | -$0.42 | N/A |
Stock Comparison
AVLN vs ONC Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, ONC has a market cap of 33.5B. Regarding current trading prices, AVLN is priced at $27.27, while ONC trades at $313.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas ONC's P/E ratio is 126.85. In terms of profitability, AVLN's ROE is N/A, compared to ONC's ROE of +0.12%. Regarding short-term risk, AVLN is more volatile compared to ONC. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check ONC's competition here
AVLN vs WBA Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, AVLN is priced at $27.27, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas WBA's P/E ratio is -1.64. In terms of profitability, AVLN's ROE is N/A, compared to WBA's ROE of -0.39%. Regarding short-term risk, AVLN is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check WBA's competition here
AVLN vs DMRA Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, DMRA has a market cap of 1.5B. Regarding current trading prices, AVLN is priced at $27.27, while DMRA trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas DMRA's P/E ratio is -6.19. In terms of profitability, AVLN's ROE is N/A, compared to DMRA's ROE of -3.12%. Regarding short-term risk, AVLN is more volatile compared to DMRA. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check DMRA's competition here
AVLN vs HROWL Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, AVLN is priced at $27.27, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas HROWL's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to HROWL's ROE of -0.10%. Regarding short-term risk, AVLN is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check HROWL's competition here
AVLN vs HROWM Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, AVLN is priced at $27.27, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas HROWM's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to HROWM's ROE of -0.10%. Regarding short-term risk, AVLN is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check HROWM's competition here
AVLN vs CGEM Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, CGEM has a market cap of 921.2M. Regarding current trading prices, AVLN is priced at $27.27, while CGEM trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas CGEM's P/E ratio is -4.46. In terms of profitability, AVLN's ROE is N/A, compared to CGEM's ROE of -0.46%. Regarding short-term risk, AVLN is more volatile compared to CGEM. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check CGEM's competition here
AVLN vs ATAI Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, ATAI has a market cap of 787.5M. Regarding current trading prices, AVLN is priced at $27.27, while ATAI trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas ATAI's P/E ratio is -1.43. In terms of profitability, AVLN's ROE is N/A, compared to ATAI's ROE of -3.90%. Regarding short-term risk, AVLN is more volatile compared to ATAI. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check ATAI's competition here
AVLN vs LFMD Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, LFMD has a market cap of 253.1M. Regarding current trading prices, AVLN is priced at $27.27, while LFMD trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas LFMD's P/E ratio is -17.58. In terms of profitability, AVLN's ROE is N/A, compared to LFMD's ROE of -1.18%. Regarding short-term risk, AVLN is more volatile compared to LFMD. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check LFMD's competition here
AVLN vs HITI Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, HITI has a market cap of 218.4M. Regarding current trading prices, AVLN is priced at $27.27, while HITI trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas HITI's P/E ratio is -5.92. In terms of profitability, AVLN's ROE is N/A, compared to HITI's ROE of -0.41%. Regarding short-term risk, AVLN is more volatile compared to HITI. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check HITI's competition here
AVLN vs LFMDP Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, LFMDP has a market cap of 161M. Regarding current trading prices, AVLN is priced at $27.27, while LFMDP trades at $23.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas LFMDP's P/E ratio is -10.47. In terms of profitability, AVLN's ROE is N/A, compared to LFMDP's ROE of -1.18%. Regarding short-term risk, AVLN is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check LFMDP's competition here
AVLN vs LFLY Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, LFLY has a market cap of 114.9M. Regarding current trading prices, AVLN is priced at $27.27, while LFLY trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas LFLY's P/E ratio is -0.04. In terms of profitability, AVLN's ROE is N/A, compared to LFLY's ROE of +0.17%. Regarding short-term risk, AVLN is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check LFLY's competition here
AVLN vs POM Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, POM has a market cap of 52.6M. Regarding current trading prices, AVLN is priced at $27.27, while POM trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas POM's P/E ratio is -9.83. In terms of profitability, AVLN's ROE is N/A, compared to POM's ROE of +0.07%. Regarding short-term risk, AVLN is less volatile compared to POM. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check POM's competition here
AVLN vs PETS Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, PETS has a market cap of 49.4M. Regarding current trading prices, AVLN is priced at $27.27, while PETS trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas PETS's P/E ratio is -0.74. In terms of profitability, AVLN's ROE is N/A, compared to PETS's ROE of -1.22%. Regarding short-term risk, AVLN is more volatile compared to PETS. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check PETS's competition here
AVLN vs YI Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, YI has a market cap of 48.5M. Regarding current trading prices, AVLN is priced at $27.27, while YI trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas YI's P/E ratio is -5.05. In terms of profitability, AVLN's ROE is N/A, compared to YI's ROE of +0.08%. Regarding short-term risk, AVLN is more volatile compared to YI. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check YI's competition here
AVLN vs SDEV Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, SDEV has a market cap of 42.9M. Regarding current trading prices, AVLN is priced at $27.27, while SDEV trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas SDEV's P/E ratio is -0.28. In terms of profitability, AVLN's ROE is N/A, compared to SDEV's ROE of +12.37%. Regarding short-term risk, AVLN is less volatile compared to SDEV. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check SDEV's competition here
AVLN vs RAD Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, AVLN is priced at $27.27, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas RAD's P/E ratio is -0.05. In terms of profitability, AVLN's ROE is N/A, compared to RAD's ROE of +2.76%. Regarding short-term risk, AVLN is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check RAD's competition here
AVLN vs RNTX Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, RNTX has a market cap of 32.9M. Regarding current trading prices, AVLN is priced at $27.27, while RNTX trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas RNTX's P/E ratio is -0.60. In terms of profitability, AVLN's ROE is N/A, compared to RNTX's ROE of -2.81%. Regarding short-term risk, AVLN is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check RNTX's competition here
AVLN vs NEUP Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, NEUP has a market cap of 29.1M. Regarding current trading prices, AVLN is priced at $27.27, while NEUP trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas NEUP's P/E ratio is -7.81. In terms of profitability, AVLN's ROE is N/A, compared to NEUP's ROE of -15.38%. Regarding short-term risk, AVLN is more volatile compared to NEUP. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check NEUP's competition here
AVLN vs KYNB Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, KYNB has a market cap of 28.7M. Regarding current trading prices, AVLN is priced at $27.27, while KYNB trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas KYNB's P/E ratio is -0.49. In terms of profitability, AVLN's ROE is N/A, compared to KYNB's ROE of -1.62%. Regarding short-term risk, AVLN is more volatile compared to KYNB. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check KYNB's competition here
AVLN vs MEDS Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, AVLN is priced at $27.27, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas MEDS's P/E ratio is -0.31. In terms of profitability, AVLN's ROE is N/A, compared to MEDS's ROE of -2.36%. Regarding short-term risk, AVLN is more volatile compared to MEDS. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check MEDS's competition here
AVLN vs CJJD Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, AVLN is priced at $27.27, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas CJJD's P/E ratio is -0.46. In terms of profitability, AVLN's ROE is N/A, compared to CJJD's ROE of -0.25%. Regarding short-term risk, AVLN is more volatile compared to CJJD. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check CJJD's competition here
AVLN vs MSLE Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, MSLE has a market cap of 9.9M. Regarding current trading prices, AVLN is priced at $27.27, while MSLE trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas MSLE's P/E ratio is -4.54. In terms of profitability, AVLN's ROE is N/A, compared to MSLE's ROE of -0.52%. Regarding short-term risk, AVLN is more volatile compared to MSLE. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check MSLE's competition here
AVLN vs SSY Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, AVLN is priced at $27.27, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas SSY's P/E ratio is -2.86. In terms of profitability, AVLN's ROE is N/A, compared to SSY's ROE of -0.15%. Regarding short-term risk, AVLN is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check SSY's competition here
AVLN vs AIXC Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, AIXC has a market cap of 7.4M. Regarding current trading prices, AVLN is priced at $27.27, while AIXC trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas AIXC's P/E ratio is -0.18. In terms of profitability, AVLN's ROE is N/A, compared to AIXC's ROE of -1.05%. Regarding short-term risk, AVLN is more volatile compared to AIXC. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check AIXC's competition here
AVLN vs HKPD Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, HKPD has a market cap of 7.1M. Regarding current trading prices, AVLN is priced at $27.27, while HKPD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas HKPD's P/E ratio is -10.83. In terms of profitability, AVLN's ROE is N/A, compared to HKPD's ROE of -0.01%. Regarding short-term risk, AVLN is less volatile compared to HKPD. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check HKPD's competition here
AVLN vs MDVL Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, AVLN is priced at $27.27, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas MDVL's P/E ratio is -0.05. In terms of profitability, AVLN's ROE is N/A, compared to MDVL's ROE of -2.39%. Regarding short-term risk, AVLN is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check MDVL's competition here
AVLN vs ATNFW Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, AVLN is priced at $27.27, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas ATNFW's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to ATNFW's ROE of -0.91%. Regarding short-term risk, AVLN is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check ATNFW's competition here
AVLN vs BGMSP Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, AVLN is priced at $27.27, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas BGMSP's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to BGMSP's ROE of -2.95%. Regarding short-term risk, AVLN is more volatile compared to BGMSP. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check BGMSP's competition here
AVLN vs NVOH Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, NVOH has a market cap of 2.3M. Regarding current trading prices, AVLN is priced at $27.27, while NVOH trades at $25.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas NVOH's P/E ratio is 13.23. In terms of profitability, AVLN's ROE is N/A, compared to NVOH's ROE of +0.00%. Regarding short-term risk, AVLN is more volatile compared to NVOH. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check NVOH's competition here
AVLN vs BGMS Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, BGMS has a market cap of 2.2M. Regarding current trading prices, AVLN is priced at $27.27, while BGMS trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas BGMS's P/E ratio is -0.15. In terms of profitability, AVLN's ROE is N/A, compared to BGMS's ROE of -0.58%. Regarding short-term risk, AVLN is more volatile compared to BGMS. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check BGMS's competition here
AVLN vs AZNH Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, AVLN is priced at $27.27, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas AZNH's P/E ratio is 38.35. In terms of profitability, AVLN's ROE is N/A, compared to AZNH's ROE of +0.00%. Regarding short-term risk, AVLN is more volatile compared to AZNH. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check AZNH's competition here
AVLN vs LFLYW Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, AVLN is priced at $27.27, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas LFLYW's P/E ratio is -0.04. In terms of profitability, AVLN's ROE is N/A, compared to LFLYW's ROE of +0.17%. Regarding short-term risk, AVLN is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check LFLYW's competition here
AVLN vs BIMI Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, BIMI has a market cap of 1.2K. Regarding current trading prices, AVLN is priced at $27.27, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas BIMI's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to BIMI's ROE of -2.94%. Regarding short-term risk, AVLN is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check BIMI's competition here
AVLN vs OREX Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, OREX has a market cap of 0. Regarding current trading prices, AVLN is priced at $27.27, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas OREX's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to OREX's ROE of -0.54%. Regarding short-term risk, AVLN is less volatile compared to OREX. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check OREX's competition here
AVLN vs SHPG Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, SHPG has a market cap of 0. Regarding current trading prices, AVLN is priced at $27.27, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas SHPG's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to SHPG's ROE of +0.13%. Regarding short-term risk, AVLN is more volatile compared to SHPG. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check SHPG's competition here
AVLN vs POZN Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, POZN has a market cap of 0. Regarding current trading prices, AVLN is priced at $27.27, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas POZN's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to POZN's ROE of +0.61%. Regarding short-term risk, AVLN is less volatile compared to POZN. This indicates potentially lower risk in terms of short-term price fluctuations for AVLN.Check POZN's competition here
AVLN vs CPD Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, CPD has a market cap of 0. Regarding current trading prices, AVLN is priced at $27.27, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas CPD's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to CPD's ROE of N/A. Regarding short-term risk, AVLN is more volatile compared to CPD. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check CPD's competition here
AVLN vs IPXL Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, IPXL has a market cap of 0. Regarding current trading prices, AVLN is priced at $27.27, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas IPXL's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to IPXL's ROE of -1.16%. Regarding short-term risk, AVLN is more volatile compared to IPXL. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check IPXL's competition here
AVLN vs ESRX Comparison May 2026
AVLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVLN stands at 1.1B. In comparison, ESRX has a market cap of 0. Regarding current trading prices, AVLN is priced at $27.27, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVLN currently has a P/E ratio of -13.37, whereas ESRX's P/E ratio is N/A. In terms of profitability, AVLN's ROE is N/A, compared to ESRX's ROE of +0.26%. Regarding short-term risk, AVLN is more volatile compared to ESRX. This indicates potentially higher risk in terms of short-term price fluctuations for AVLN.Check ESRX's competition here